Evidence map›Paper›PMID 28507730›Full record

ReviewClinical and translational allergy2017

Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins.

Jolanda H M van Bilsen, Edyta Sienkiewicz-Szłapka, Daniel Lozano-Ojalvo, Linette E M Willemsen, Celia M Antunes, Elena Molina, Joost J Smit, Barbara Wróblewska, Harry J Wichers, Edward F Knol and 8 more

Abstract readReview
In one paragraph

Review in Clinical and translational allergy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. An advancedFrontiers in immunology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jolanda H M van BilsenTNO, PO Box 360, 3700 AJ Zeist, The Netherlands.
Edyta Sienkiewicz-SzłapkaUniversity of Warmia and Mazury, Olsztyn, Poland.
Daniel Lozano-OjalvoInstituto de Investigación en Ciencias de la Alimentación, Madrid, Spain.
Linette E M WillemsenUtrecht University, Utrecht, The Netherlands.
Celia M AntunesUniversity of Evora, Évora, Portugal.
Elena MolinaInstituto de Investigación en Ciencias de la Alimentación, Madrid, Spain.
Joost J SmitUtrecht University, Utrecht, The Netherlands.
Barbara WróblewskaInstitute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Poland.
Harry J WichersWageningen University and Research, Wageningen, The Netherlands.
Edward F KnolUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Gregory S LadicsDuPont Company, Newark, NJ USA.
Raymond H H PietersUtrecht University, Utrecht, The Netherlands.
Sandra Denery-PapiniINRA, Nantes, France.
Yvonne M VissersNestlé Ltd., Nestlé Research Center, Lausanne, Switzerland.
Simona L BavaroInstitute of Sciences of Food Production, National Research Council, Bari, Italy.
Colette LarréINRA, Nantes, France.
Kitty C M VerhoeckxTNO, PO Box 360, 3700 AJ Zeist, The Netherlands.
Erwin L Roggen3Rs Managing and Consulting ApS, Lyngby, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe introduction of whole new foods in a population may lead to sensitization and food allergy. This constitutes a potential public health problem and a challenge to risk assessors and managers as the existing understanding of the pathophysiological processes and the currently available biological tools for prediction of the risk for food allergy development and the severity of the reaction are not sufficient. There is a substantial body of in vivo and in vitro data describing molecular and cellular events potentially involved in food sensitization. However, these events have not been organized in a sequence of related events that is plausible to result in sensitization, and useful to challenge current hypotheses. The aim of this manuscript was to collect and structure the current mechanistic understanding of sensitization induction to food proteins by applying the concept of adverse outcome pathway (AOP). MAIN BODY: The proposed AOP for food sensitization is based on information on molecular and cellular mechanisms and pathways evidenced to be involved in sensitization by food and food proteins and uses the AOPs for chemical skin sensitization and respiratory sensitization induction as templates. Available mechanistic data on protein respiratory sensitization were included to fill out gaps in the understanding of how proteins may affect cells, cell-cell interactions and tissue homeostasis. Analysis revealed several key events (KE) and biomarkers that may have potential use in testing and assessment of proteins for their sensitizing potential.

conclusionThe application of the AOP concept to structure mechanistic in vivo and in vitro knowledge has made it possible to identify a number of methods, each addressing a specific KE, that provide information about the food allergenic potential of new proteins. When applied in the context of an integrated strategy these methods may reduce, if not replace, current animal testing approaches. The proposed AOP will be shared at the www.aopwiki.org platform to expand the mechanistic data, improve the confidence in each of the proposed KE and key event relations (KERs), and allow for the identification of new, or refinement of established KE and KERs.

Indexed as

Adverse outcome pathwayFood allergyFood proteinsKey event relationsKey eventsMechanistic understandingMolecular initiating eventSensitization

Identifiers

PMID28507730
PMCPMC5429547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.